Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma

Status Recruiting

Clinical Trial Summary

Endometrial carcinoma represents the most common gynaecological cancer and the sixth most frequent cancer among women worldwide. The 5-year survival of patients with stage I endometrial carcinoma is 75%-88% versus 50% for stage III or 15% for stage IV disease. Therefore, early detection could improve survival rates. Specifically, in the most prevalent, type 1 endometrial cancer develops from hyperplastic endometrium. The aim of the study was to evaluate the utility of cancer gene mutations from endometrial biopsies towards predicting synchronous or metachronous development of malignant lesions. The aim of the study was to evaluate whether endometrial biopsies could already carry mutations in cancer genes useful for predicting or anticipating subsequent cancer development

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05273099
Study type	Observational
Source	Università degli Studi di Ferrara
Contact	Gennaro Scutiero, MD
Phone	+390532236657
Email	gennaro.scutiero@unife.it
Status	Recruiting
Phase
Start date	March 1, 2022
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00377520` - A Trial for Patients With Advanced/Recurrent Endometrial Cancer	Phase 2
Recruiting	`NCT05179824` - Tempus Priority Study: A Pan-tumor Observational Study
Completed	`NCT02387645` - LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma	N/A
Recruiting	`NCT04438564` - Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients	N/A
Recruiting	`NCT05742711` - Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients	N/A
Suspended	`NCT06253494` - Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer	Phase 1/Phase 2
Completed	`NCT04891146` - The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
Completed	`NCT05233059` - FitEx for Endometrial Cancer Survivors	N/A
Recruiting	`NCT02545348` - Use of the Sentinel Node Biopsy for Early Endometrial Cancer.
Recruiting	`NCT00726635` - The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies	Phase 3
Completed	`NCT00859768` - The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients	N/A